United States · Pharmaceuticals
United States · PharmaceuticalsIroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
PrivateFor profit
Why reach out now
What the record says about Iroko Pharmaceuticals as a customer or partner.
- Part of Egalet CorporationBuying decisions may sit with the parent company.
Against its peers
Set against 3,670 Pharmaceuticals companies in United States. The ring marks the typical peer.
Across all 5.9M companies: larger than 75% of those with a size listed; older than 40% of those with a founding year.
About Iroko Pharmaceuticals
BiotechnologyLife SciencePharmaceutical
b2b
One of 3,670 Pharmaceuticals companies in United States, and of 11,490 in the industry worldwide.
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$215M
raised in total across 2 rounds
Last raised Jun 2016, 10 years ago
- Rounds
- 2
- Latest round
- Debt financing
- Latest amount
- $140M
- Investors
- 22 leading
Corporate family
Where it sits in its group, and the deals it has done.
Key facts
Who started it and how it trades.
- Founded by
- Osagie O. Imasogie
- Annual revenue
- $50M
- NAICS code
- 325412
Every detail we hold
Everything the source datasets list about Iroko Pharmaceuticals, field by field. Contact details are held but never shown.
The company7 fields
- Name
- Iroko Pharmaceuticals
- Type
- For profit
- Status
- Private
- Founded
- 2007
- Founders
- Osagie O. Imasogie
- Industry
- Pharmaceuticals
- Categories
- Biotechnology, Life Science, Pharmaceutical
Where4 fields
- City
- Philadelphia
- Region
- Pennsylvania
- Country
- United States
- Markets
- Greater Philadelphia Area, Great Lakes, Northeastern US
Size and reach2 fields
- Staff band
- 51-100
- Annual revenue
- $50M
Show 15 more fieldsShow fewer fields
Funding, as listed8 fields
- Total
- $215,000,000 USD
- Rounds
- 2
- Latest round
- Debt financing
- Latest round date
- Jun 2016
- Latest amount
- 140,000,000 USD
- Investors
- 2
- Lead investors
- 2
- Listing status
- private
Corporate family2 fields
- Part of
- Egalet Corporation
- Parent website
- egalet.com
Classification3 fields
- NAICS
- 325412
- SIC
- 2834
- Keywords
- 1 listed, shown above
About this record2 fields
- Sources
- Crunchbase, Apollo
- Last imported
- Sept 2026
Growth, as the source summarises it
Iroko Pharmaceuticals may be growing as it is listed among several companies in a report about the axial spondyloarthritis market, which is expected to register immense growth during the forecast period. Being included in a market with a positive growth forecast suggests that the company is part of an expanding industry segment. This inclusion indicates that Iroko Pharmaceuticals is active in a sector that is attracting attention and investment, which can be beneficial for its business prospects.
Companies like Iroko Pharmaceuticals
Pharmaceuticals in United States: 3,670 in the directory.
PCI Pharma ServicesPhiladelphia · 5001-10000 peoplefounded 40 years earlierAAmneal PharmaceuticalsBridgewater · 5001-10000 peoplefounded 12 years earlierssanofi-aventis U.SBridgewater · 10001+ peoplefounded 3 years earlier
NovavaxGaithersburg · 1001-5000 peoplefounded 20 years earlierRReata PharmaceuticalsPlano · 251-500 peoplefounded 5 years earlierPPortola PharmaceuticalsSouth San Francisco · 51-100 peoplefounded 4 years earlierBuild a lead list
3,670 Pharmaceuticals companies in United States, filtered by size, age and reach, ready to export with emails on Pro.